Cargando...

Gonadotrophin-releasing Hormone Therapy in Hypogonadal Males with Hypothalamic or Pituitary Dysfunction

Subcutaneous self-administration of synthetic gonadotrophin-releasing hormone 500 μg eight-hourly for up to one year by 12 male patients (five prepubertal) with clinical hypogonadism due to hypothalamic or pituitary disease resulted in the synthesis and continued release of luteinizing hormone (LH)...

Descrición completa

Gardado en:
Detalles Bibliográficos
Main Authors: Mortimer, C. H., McNeilly, A. S., Fisher, R. A., Murray, M. A. F., Besser, G. M.
Formato: Artigo
Idioma:Inglês
Publicado: 1974
Assuntos:
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC1612996/
https://ncbi.nlm.nih.gov/pubmed/4613417
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!